China has now approved GLP-1 therapies from Eli Lilly (Mounjaro), Innovent Biologics (mazdutide), and Guangzhou Innogen (efsubaglutide alfa), in addition to Xianyida
By supporting this barrier, pantothenic acid may help reduce moisture loss and protect eczema-prone skin from irritants
The study involved 98 obese adults, HealthDay News reported on the 18th
de Kluiver H, Jansen R, Penninx BWJH, Giltay EJ, Schoevers RA, Milaneschi Y
Which treatment option is medically appropriate can also be assessed depending on the individual starting point, including in comparison with Mounjaro or Saxenda
But with that power comes risk